title: Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation.
authors.affiliation: Chang Gung Memorial Hospital, Taipei, Taiwan.
authors.forename: Jui-Hung
authors.initials: JH
authors.lastname: Ko
authors.forename: Yi-Chin
authors.initials: YC
authors.lastname: Shih
authors.forename: Rosaline Chung-Yee
authors.initials: RC
authors.lastname: Hui
authors.forename: Chih-Hsun
authors.initials: CH
authors.lastname: Yang
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001707:Biopsy, Needle; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005500:Follow-Up Studies; D000077156:Gefitinib; D006801:Humans; D007150:Immunohistochemistry; D035002:Lower Extremity; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009336:Necrosis / Q000139:chemically induced / Q000188:drug therapy; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D011239:Prednisolone / Q000008:administration & dosage; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D017445:Skin Diseases, Vascular / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D016896:Treatment Outcome; D014657:Vasculitis / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D011239:Prednisolone; D000077156:Gefitinib